Cardiovascular Research
Familial hypobetalipoproteinemia patients have decreased CV risk
Published in Cardiovascular Week, October 24th, 2005
Investigators in the Netherlands report, "Individuals with familial hypobetalipoproteinemia (FHBL) have been reported to be prone to fatty liver disease (FLD). Conversely, the profound reduction of low-density lipoprotein (LDL) cholesterol in this disorder might decrease cardiovascular risk."
R.R. Sankatsing and colleagues of the Academic Medical Center in Amsterdam wrote, "In [our] study, we assessed hepatic steatosis as well as noninvasive surrogate markers for cardiovascular disease (CVD) in subjects with FHBL and in matched controls. Hepatic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2005-10-24)
More Articles from Cardiovascular Week
- Atherosclerosis
Chronic infections modify lipid profile to increase risk of atherosclerosis - Cardiovascular Disease
Alpha-adducin Gly460Trp polymorphism is strong predictor of CV mortality - Cardiovascular Research
Circulating endothelial progenitor cells predict CV events and death - Lipid Research
Lp-PLA2 may be an independent risk marker for coronary artery disease - Proteomics
List of CV-related proteins in plasma constitutes a baseline proteomic blueprint - Adverse Drug Reaction
OKT3 and daclizumab effectively avert early acute rejection of heart transplants - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
